| Financial Year |
March 31 2023 |
| Monetary Funds |
773,757,871.11 |
| Held-for-trading Financial Assets |
182,034,487.05 |
| Notes Receivable |
56,808,135.50 |
| Accounts Receivable |
572,867,829.47 |
| Advances to Suppliers |
18,109,336.04 |
| Other Receivables |
21,642,835.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
682,632,862.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
338,679,993.09 |
| Total Current Assets |
2,648,738,444.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
780,689.23 |
| Long-term Equity Investment |
474,020,417.17 |
| Investment Properties |
8,598,710.03 |
| Fixed Assetes |
1,076,836,198.29 |
| Under-construction Projects |
1,043,677,876.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
388,263,544.79 |
| R&D expenses |
-- |
| Goodwill |
6,505,548.53 |
| Long-Term Deferred and Prepaid Expenses |
55,763,140.03 |
| Deferred Income Tax Assets |
333,234,198.03 |
| Other Non-Current Assets |
162,734,836.52 |
| Sub-Total of Non-Current Assets |
3,737,158,093.39 |
| Total Assets |
6,385,896,537.57 |
| Short-Term Loans |
250,898,337.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
87,266,123.52 |
| Accounts Payable |
653,982,029.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
65,701,005.40 |
| Taxes Payable |
27,076,733.91 |
| Interest Payable |
1,063,939.09 |
| Dividend Payable |
-- |
| Other payables |
71,995,193.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
53,014,180.43 |
| Other Current Liabilities |
1,605,967.73 |
| Sub-Total of Current Liabilities |
1,215,802,392.26 |
| Long-term Loans |
244,302,510.78 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,335,835.56 |
| Deferred Income Tax Liabilities |
42,653,939.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
448,383,483.78 |
| Total Liabilities |
1,664,185,876.04 |
| Paid-In Capital(Or Share Stock) |
767,498,006.00 |
| Capital Surplus |
4,612,526,786.34 |
| Surplus Reserve |
103,509,761.54 |
| LESS:Treasury Stock |
61,656,003.86 |
| Undistributed Profits |
-866,735,363.27 |
| Minority Stockholder's Interest |
164,839,515.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,556,871,145.74 |
| Owner's Equity（Stockholder's Equity） |
4,721,710,661.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,385,896,537.57 |
